Seereverse Karen A. Spencer
FDA investigator
Appears on 1 document from 2022, mostly at sites in New Jersey. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 16.0
- Observations per 483
- 2022
- First seen
- 2022
- Most recent
What they cite most
From 16 observations- 21 CFR 211.160General requirements2
- 21 CFR 211.194Laboratory records2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 111.105What must quality control personnel do?1
- 21 CFR 111.113What quality control operations are required for a material review and disposition decision?1
- 21 CFR 111.123What quality control operations are required for the master manufacturing record, the batch production record, and manufacturing operations?1
Activity by year
2022: 1
Where
New Jersey 1
Often inspects with
Is Seereverse Karen A. Spencer coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-02-03 | 483 Aspire Pharmaceuticals Inc.Feb 3, 2022 · Somerset, New Jersey | Somerset, New Jersey | 16 |
About this profile
What does Seereverse Karen A. Spencer inspect?
Seereverse Karen A. Spencer appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.194 and 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Seereverse Karen A. Spencer is dated Feb 3, 2022.